News and Announcements
QHeart Medical – First Australian Private Company to Receive AISRF Support
- Published January 12, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- QHeart Medical (BioQ Devices Pty Ltd) only private research organisation to be awarded prestigious Australia India strategic research fund (AISRF) grant of $1Million.
- QHeart Medical participated in the Wholesale Investor Life Sciences event in Singapore to connect with Investors in the Asian region.
- QHeart Medical prepares for investment and showcases on the Wholesale Investor site.
- Winners of the QUT J&J Partnering Office pitch session (Dec 2017) with free entry into the 2018 MTPConnect BridgeTech Commercialisation program.
- World First Study: QHeart Medical successfully implanted their “pumpless” BioQ Cardiac Assist device using a minimally invasive procedure (MIS) on pigs QUT MERF, Brisbane (Dec 2017), avoiding open chest surgery and allow faster patient recovery.
QHeart Medical in collaboration with Frontier Lifeline Hospital, UNSW and QUT, are developing a revolutionary heart failure treatment device for heart failure which is highly unserved with cost effective and preventative treatment options and carries a massive economic burden to society. QHeart’s cost effective cardiac assist device, the BioQ CA, requires no pump or control system, and is designed to improve Quality of Life and reduce healthcare costs for millions of unserved patients worldwide. The Federal Government is supporting the program with the awarding of the prestigious Australia-India Strategic Fund (AISRF) grant.
In Oct’2017, QHeart Medical team presented at the Wholesale Investor Life Science event in Singapore to develop investor contacts.
In Dec’2017, QHeart Medical successfully placed the BioQ Cardiac Assist Device using minimally invasive procedure (MIS) on Pigs aorta at MERF, QUT, Brisbane. This will minimise the operating procedure time and assist faster patient recovery, and reduce treatment costs for this revolutionary affordable therapy.
In 2018, QHeart Medical is seeking further capital to accelerate the commercialisation activities of the BioQ CA heart failure treatment.
About QHeart Medical
QHeart Medical is commercialising a revolutionary heart failure treatment device for heart failure and hypertension which are highly unserved with cost-effective and preventative treatment options and carry a massive economic burden to society.
Our cost-effective self-powered cardiac assist device, the BioQ CA, requires no pump or control system, and aims to improve Quality of Life and reduce healthcare costs for millions of unserved patients worldwide.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
